Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Arthritis & Rheumatism

• Publication date

  1993-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.1780361006PMID 8216395
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gold salts in the treatment of rheumatoid arthritis. A double-blind study.

  2020cited by this paper
• Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1992cited by this paper
• Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1992cited by this paper
• A double-blind comparison of parenteral methotrexate and parenteral gold in the treatment of early erosive rheumatoid arthritis: an interim report on 102 patients after 12 months.

  1991cited by this paper
• Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy. A controlled study.

  1991cited by this paper
• Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study.

  1991cited by this paper
• Can treatment with methotrexate influence the radiological progression of rheumatoid arthritis ?

  1990cited by this paper
• Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis.

  1990cited by this paper
• Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression.

  1989cited by this paper
• Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment.

  1989cited by this paper
• Does aggressive therapy of rheumatoid arthritis affect outcome?

  1989cited by this paper
• Methotrexate treatment of rheumatoid arthritis: effects on radiological progression.

  1989cited by this paper
• Methotrexate in rheumatoid arthritis.

  1988cited by this paper
• Methotrexate in Rheumatoid Arthritis: Indications, Contraindications, Efficacy, and Safety

  1987cited by this paper
• Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study.

  1987cited by this paper
• Methotrexate in rheumatoid arthritis. Health and Public Policy Committee, American College of Physicians.

  1987cited by this paper
• Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial.

  1987cited by this paper
• Assessment of radiologic progression in rheumatoid arthritis. A randomized, controlled trial.

  1986cited by this paper
• The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

  1986cited by this paper
• Efficacy of low-dose methotrexate in rheumatoid arthritis.

  1985cited by this paper
• How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

  1985cited by this paper
• Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1985cited by this paper
• Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

  1985cited by this paper
• A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.

  1984cited by this paper
• Methotrexate therapy in rheumatoid arthritis: 15 years experience.

  1983cited by this paper
• Preliminary criteria for clinical remission in rheumatoid arthritis.

  1981cited by this paper
• Low dose pulse methotrexate therapy in rheumatoid arthritis.

  1980cited by this paper
• Low dose pulse methotrexate therapy in rheumatoid arthritis.

  1980cited by this paper
• Methotrexate for psoriasis in weekly oral doses.

  1969cited by this paper
• METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS.

  1964cited by this paper
• THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITY: II. Effect of Aminopterin in Rheumatoid Arthritis and Psoriasis

  1951cited by this paper
• Therapeutic criteria in rheumatoid arthritis.

  1949cited by this paper

• Comparative Study on Methotrexate alone Versus Combination Therapy with Methotrexate Plus Chloroquine Plus Low Dose Prednisolone in the Treatment of Rheumatoid Arthritis

  2017cites this paper
• A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate

  2015cites this paper
• Current immunotherapy in rheumatoid arthritis.

  2013cites this paper
• Bone Scintigraphy in Arthritis

  2012cites this paper
• A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs

  2012cites this paper
• Regulation of cellar cytokine production and NF-κB pathway by ginseng and ginsenosides

  2012cites this paper
• Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis

  2012cites this paper
• Efficacy and Safety of CH-1504, a Metabolically Stable Antifolate, in Patients with Active Rheumatoid Arthritis: Results of a Phase II Multicenter Randomized Study

  2011cites this paper
• Cost‐effectiveness of biologic response modifiers compared to disease‐modifying antirheumatic drugs for rheumatoid arthritis: A systematic review

  2011cites this paper
• Radiographic measurements in the evaluation and classification of elbow joint destruction in patients with rheumatoid arthritis

  2010cites this paper
• Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.

  2010cites this paper
• Traditional herbal medicines (Kampo) for patients with rheumatoid arthritis receiving concomitant methotrexate: a preliminary study.

  2010cites this paper
• CHAPTER 10C – Methotrexate: The Foundation of Rheumatoid Arthritis Therapy

  2009cites this paper
• Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis

  2008cites this paper
• PROGRAMA DE PÓS-GRADUAÇÃO EM ODONTOLOGIA NÍVEL: MESTRADO ÁREA DE CONCENTRAÇÃO: PERIODONTIA

  2007cites this paper
• Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs

  2007cites this paper
• Etanercept in severe active rheumatoid arthritis: first Australian experience

  2006cites this paper
• A critical appraisal of radiographic scoring systems for assessment of juvenile idiopathic arthritis

  2006cites this paper
• Aspectos actuales y perspectivas de futuro del tratamiento de la artritis reumatoide

  2006cites this paper
• A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

  2005cites this paper
• The influence of N-acetyltransferase 2 polymorphism on rheumatoid arthritis activity.

  2004cites this paper
• The treatment of rheumatoid arthritis.

  2004cites this paper
• Efficacy and safety of the fully human anti-tumour necrosis factor a monoclonal antibody adalimumab ( D 2 E 7 ) in DMARD refractory patients with rheumatoid arthritis : a 12 week , phase II study

  2003cites this paper
• Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study.

  2003cites this paper
• Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.

  2003cites this paper
• Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis

  2003cites this paper
• Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

  2003cites this paper
• Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned?

  2003cites this paper
• Practical Prescribing Guidelines for Rheumatoid Arthritis

  2003cites this paper
• Safety and Efficacy of Disease-Modifying Anti-Rheumatic Agents

  2002cites this paper
• [Combination therapy for rheumatoid arthritis].

  2002cites this paper
• Treating rheumatoid arthritis with new disease modifying drugs.

  2002cites this paper
• MTX affects inflammation and tissue destruction differently in the rat AA model.

  2001cites this paper
• Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone.

  2001cites this paper
• Tetracyclines in Biology, Chemistry and Medicine

  2001cites this paper
• Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine.

  2001cites this paper
• Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs.

  2001cites this paper
• Association of clinical, radiological and synovial immunopathological responses to anti-rheumatic treatment in rheumatoid arthritis.

  2001cites this paper
• A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.

  2000cites this paper
• Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective

  2000cites this paper
• Enhanced production of tissue inhibitor of metalloproteinases by peripheral blood mononuclear cells of rheumatoid arthritis patients responding to methotrexate treatment.

  2000cites this paper
• Methotrexate use in rheumatoid arthritis. A Clinician's perspective.

  2000cites this paper
• Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial

  2000cites this paper
• A review of controlled clinical trials examining the effects of antimalarial compounds and gold compounds on radiographic progression in rheumatoid arthritis.

  2000cites this paper
• Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine.

  2000cites this paper
• Systematic Review of Combination DMARD Therapy in Rheumatoid Arthritis

  2000cites this paper
• Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug.

  1999cites this paper
• Radiologic progression in early rheumatoid arthritis treated with methotrexate.

  1999cites this paper
• Disease modification in rheumatoid arthritis with leflunomide.

  1999cites this paper
• Methotrexate and radiographic disease progression in patients with rheumatoid arthritis.

  1999cites this paper
• Combination therapy in rheumatoid arthritis: updated systematic review.

  1998cites this paper
• Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset

  1998cites this paper
• Methotrexate in Rheumatoid Arthritis

  1997cites this paper
• Methotrexate as the initial second-line disease modifying agent in the treatment of rheumatoid arthritis patients.

  1997cites this paper
• Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A or methotrexate: comment on the article by Pasero et al.

  1997cites this paper
• Methotrexate use in rheumatoid arthritis.

  1997cites this paper
• Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.

  1997cites this paper
• Treatment of rheumatoid arthritis.

  1997cites this paper
• Auranofin.

  1997cites this paper
• Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34

  1997cites this paper
• Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study.

  1997cites this paper
• In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts.

  1996cites this paper
• Palpitations and fatigue in a football player.

  1996cites this paper
• Quantitative measurement of erosion growth and joint space loss in rheumatoid arthritis hand radiographs.

  1996cites this paper
• Radiologische Verlaufsanalyse bei rheumatoider Arthritis unter Methotrexat- und Sulfasalazintherapie

  1996cites this paper
• Efficacy of methotrexate in rheumatoid arthritis.

  1995cites this paper
• [Combination therapy in chronic polyarthritis].

  1995cites this paper
• Disease-Modifying Antirheumatic Drugs

  1995cites this paper
• Disease-modifying antirheumatic drugs. Potential effects in older patients.

  1995cites this paper
• Second-line drug therapy for rheumatoid arthritis.

  1994cites this paper